The 56-week OSTRO trial evaluated the efficacy and safety of benralizumab, an interleukin-5 antagonist, in 413 adult patients with severe nasal polyposis. Treatment with benralizumab was associated ...
Benralizumab (Fasenra) significantly reduced nasal polyp score (NPS) and average nasal blockage score (NBS) compared with placebo for patients with severe chronic rhinosinusitis with nasal polyps ...
Nasal polyps are noncancerous growths that can form in the nasal cavity. Although benign, they can have a significant impact on a person’s quality of life. Nasal polyps often occur along with ...
Competition among biologics that target inflammatory respiratory disease is heating up even further. On Thursday, AstraZeneca said its Fasenra, used in tandem with standard steroids, significantly ...
Do you also suffer from a constant nose block but have no cold when diagnosed? This can be a tricky condition where you might need clarification about what is happening to your nose. We talked to Dr ...
Surgery was more effective than medical management for patients with nasal obstruction associated with septal deviation, the multicenter NAIROS trial found. Patient-reported Sino-Nasal Outcome Test-22 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results